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LETTER TO THE EDITOR 
Comparison 0f Vasopressin Versus Epinephrine 
Effects in Survival of Patients with Asystole: A 
Double-Blinded Randomized Clinical Trial Study 
 
 
Dear Editor, 
Cardiovascular-related diseases are the most common 
causes of cardiac arrest in adult population.1 Reported 
survival of 2-24% is the outcome of this serious 
condition despite of rigorous attempts during 
cardiopulmonary resuscitation.2 Because of poor clinical 
yield with epinephrine usage,3 studies focused on 
possible alternative pharmacological agents. 
Vasopressin was regarded as a remedy based on some 
observations implied high concentration of this 
endogenous medication during cardiac arrest.4,5 Several 
clinical trials were also performed in different settings 
with supportive and opposing results.6-8 Considering the 
diversities in previous studies that may arise from 
clinical expertise, out-of-hospital managements and 
other background problems, this double-blinded 
randomized controlled trial aimed to assess outcomes 
such as return of spontaneous circulation (ROSC), 
survival at 1 hour, 1 day and 1 month, and mean 
survival time, only in asystole patients, who were 
treated with either vasopressin or epinephrine. 
Our study was performed in Emergency 
Department (ED) of a large teaching hospital 
affiliated to Tehran University of Medical Sciences. 
After confirming asystole in 2 of 3 limb leads in 
cardiac monitoring, the patients were assigned to 
receive vasopressin (intervention group) or 
epinephrine (controll group) with block 
randomization. Individuals with pregnancy, age less 
than 8 years old, not to resuscitate order or condition, 
delayed resuscitation more than 20 minutes of cardiac 
arrest and hemorrhagic shock were excluded from the 
study. Twent five patients were determined for each 
group. Sixty two patients were eligible for study but 7 
of 62 patients were traumatic victims and in 
hemorrhagic shock, therefore were excluded. Four of 
62 patients were in end stage of malignancy and 
resuscitation efforts were not started. One patient was 
excluded from the study because of delay in 
beginning of resuscitation more than 20 minutes. 
Finally, 50 patients were enrolled using a 
convenience sampling method. Recommended doses 
of epinephrine (1 mg, IV) or vasopressin (40 U, IV) 
were prepared in coded identical syringes blindly for 
resuscitation team members. Packages were randomly 
distributed based on a random digit table among 
cardiac arrest carts. If patients remained asystole after 
initial doses of either vasopressin or epinephrine, they 
would have received 1 mg of epinephrine for 
subsequent doses. Resuscitation team members were 
the same for all victims. Our primary outcome was 
restoring spontaneous carotid pulsation.  
The study results were shown in the Table 1. 
Comparisons between groups were done using the 
student’s t-test for continuous variables and the Chi-
Square test for categorical variables. 
Mean of survival time was calculated in each 
group except for one case of vasopressin group 
survived for one month who did not take into 
account. The medians of overall survival time were 8 
hrs and 6 hrs in vasopressin and epinephrine groups, 
respectively. In this clinical trial with an acceptable 
power of 80%, we failed to show any improvement in 
vasopressin group for either short-term or long-term 
survival indices. 
Another study investigated 200 patients with PEA, 
asystole, VT or VF randomized on the same protocol. 
They concluded no superiority for vasopressin over 
Table 1: Demographic characteristics and survival outcomes for two study groups 
Variable Vasopressin group Epinephrine group P value 
Mean of age 72.16±8.19 71.52±9.03  0.794 
Sex (Men %) 11 (44) 12 (48) - 
Sex (women %) 14 (56) 13 (52) - 
Return of spontaneous circulation (%)   9 (36) 10 (40) ≈1.00 
Survival in first hour (%)   7 (28)   7 (28)  1.00 
Survival in first 24hr (%)   3 (12)   2 (8) ≈1.00 
Median for overall survival time   8 hrs   6 hrs ≈1.00 
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epinephrine regarding in-hospital cardiac arrest.3 To 
explain the differences observed in various studies, 
including ours, some points should be considered 
such as time elapsed from cardiac events to start 
resuscitation, underlying condition (leading to 
acidosis, hypoxia, etc), type of cardiac event (VT, 
VF, asystole or …) and in-hospital/out-of-hospital 
arrest. Several limitations of our study were 
considered such as small sample size in comparison 
to other studies and undifferentiated bachground 
diagnosis as a cause of asystole in the patients. We 
tried to control the confounding effects of these 
diversities with good randomization. Distribution of 
these confounders was not similar among conducted 
studies that, in turn, could have resulted in diverse 
results. This study showed that vasopressin could be 
used just once as alternative to epinephrine in 
resuscitation of the patients with asystole. 
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